Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo:: A model for early detection and prevention of Ebola hemorrhagic fever

被引:25
作者
Lloyd, ES
Zaki, SR
Rollin, PE [1 ]
Tshioko, K
Bwaka, MA
Ksiazek, TG
Calain, P
Shieh, WJ
Kondé, MK
Verchueren, E
Perry, HN
Manguindula, L
Kabwau, J
Ndambi, R
Peters, CJ
机构
[1] Ctr Dis Control & Prevent, Speical Pathogens Branch, NCID, DVRD, Mailstop G-14,1600 Clifton Rd, Atlanta, GA 30333 USA
[2] WHO, Kinshasa, DEM REP CONGO
[3] US Agcy Int Dev, Kinshasa, DEM REP CONGO
[4] Minist Hlth, Kinshasa, DEM REP CONGO
[5] Hop Gen Reference Kikwit, Kikwit, Rep Congo
[6] Mosango Mission Hosp, Mosango, Rep Congo
[7] Medecins Frontieres, Brussels, Belgium
关键词
D O I
10.1086/514312
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
After the large-scale outbreak of Ebola hemorrhagic fever (EHF) in Bandundu region, Democratic Republic of the Congo, a program was developed to help detect and prevent future outbreaks of EHF in the region. The long-term surveillance and prevention strategy is based on early recognition by physicians, immediate initiation of enhanced barrier-nursing practices, and the use of an immunohistochemical diagnostic test performed on formalin-fixed skin specimens of patients who die of suspected viral hemorrhagic fever. The program was implemented in September 1995 during a 4-day workshop with 28 local physicians representing 17 of 22 health zones in the region, Specimen collection kits were distributed to clinics in participating health zones, and a follow-up evaluation was conducted after 6 months. The use of a formalin-fixed skin specimen for laboratory confirmation of EHF can provide an appropriate method for EHF surveillance when linked with physician training, use of viral hemorrhagic fever isolation precautions, and follow-up investigation.
引用
收藏
页码:S274 / S280
页数:7
相关论文
共 33 条
[1]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[2]  
BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997
[3]  
Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
[4]   Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995 [J].
Busico, KM ;
Marshall, KL ;
Ksiazek, TG ;
Roels, TH ;
Fleerackers, Y ;
Feldmann, H ;
Khan, AS ;
Peters, CJ .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S102-S107
[5]   Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients [J].
Bwaka, MA ;
Bonnet, MJ ;
Calain, P ;
Colebunders, R ;
De Roo, A ;
Guimard, Y ;
Katwiki, KR ;
Kibadi, K ;
Kipasa, MA ;
Kuvula, KJ ;
Mapanda, BB ;
Massamba, M ;
Mupapa, KD ;
Muyembe-Tamfum, JJ ;
Ndaberey, E ;
Peters, CJ ;
Rollin, PE ;
Van den Enden, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S1-S7
[6]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P475
[7]  
Centers for Disease Control and Prevention/World Health Organization, 1998, INF CONTR VIR HAEM F, P1
[8]  
Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1
[9]  
Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247
[10]   Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995 [J].
Dowell, SF ;
Mukunu, R ;
Ksiazek, TG ;
Khan, AS ;
Rollin, PE ;
Peters, CJ .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S87-S91